Cargando…
Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients
Neurological phenotypes such as intellectual disability occur in almost half of patients with neurofibromatosis 1 (NF1). Current genotype–phenotype studies have failed to reveal the mechanism underlying this clinical variability. Despite the presence of pathogenic variants of NF1, modifier genes lik...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778305/ https://www.ncbi.nlm.nih.gov/pubmed/36553485 http://dx.doi.org/10.3390/genes13122218 |
_version_ | 1784856325671354368 |
---|---|
author | Tang, Jie Li, Niu Li, Guoqiang Wang, Jian Yu, Tingting Yao, Ruen |
author_facet | Tang, Jie Li, Niu Li, Guoqiang Wang, Jian Yu, Tingting Yao, Ruen |
author_sort | Tang, Jie |
collection | PubMed |
description | Neurological phenotypes such as intellectual disability occur in almost half of patients with neurofibromatosis 1 (NF1). Current genotype–phenotype studies have failed to reveal the mechanism underlying this clinical variability. Despite the presence of pathogenic variants of NF1, modifier genes likely determine the occurrence and severity of neurological phenotypes. Exome sequencing data were used to identify genetic variants in 13 NF1 patients and 457 healthy controls, and this information was used to identify candidate modifier genes underlying neurological phenotypes based on an optimal sequence kernel association test. Thirty-six genes were identified as significant modifying factors in patients with neurological phenotypes and all are highly expressed in the nervous system. A review of the literature confirmed that 19 genes including CUL7, DPH1, and BCO1 are clearly associated with the alteration of neurological functioning and development. Our study revealed the enrichment of rare variants of 19 genes closely related to neurological development and functioning in NF1 patients with neurological phenotypes, indicating possible modifier genes and variants affecting neurodevelopment. Further studies on rare genetic variants of candidate modifier genes may help explain the clinical heterogeneity of NF1. |
format | Online Article Text |
id | pubmed-9778305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97783052022-12-23 Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients Tang, Jie Li, Niu Li, Guoqiang Wang, Jian Yu, Tingting Yao, Ruen Genes (Basel) Article Neurological phenotypes such as intellectual disability occur in almost half of patients with neurofibromatosis 1 (NF1). Current genotype–phenotype studies have failed to reveal the mechanism underlying this clinical variability. Despite the presence of pathogenic variants of NF1, modifier genes likely determine the occurrence and severity of neurological phenotypes. Exome sequencing data were used to identify genetic variants in 13 NF1 patients and 457 healthy controls, and this information was used to identify candidate modifier genes underlying neurological phenotypes based on an optimal sequence kernel association test. Thirty-six genes were identified as significant modifying factors in patients with neurological phenotypes and all are highly expressed in the nervous system. A review of the literature confirmed that 19 genes including CUL7, DPH1, and BCO1 are clearly associated with the alteration of neurological functioning and development. Our study revealed the enrichment of rare variants of 19 genes closely related to neurological development and functioning in NF1 patients with neurological phenotypes, indicating possible modifier genes and variants affecting neurodevelopment. Further studies on rare genetic variants of candidate modifier genes may help explain the clinical heterogeneity of NF1. MDPI 2022-11-26 /pmc/articles/PMC9778305/ /pubmed/36553485 http://dx.doi.org/10.3390/genes13122218 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tang, Jie Li, Niu Li, Guoqiang Wang, Jian Yu, Tingting Yao, Ruen Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients |
title | Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients |
title_full | Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients |
title_fullStr | Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients |
title_full_unstemmed | Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients |
title_short | Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients |
title_sort | assessment of rare genetic variants to identify candidate modifier genes underlying neurological manifestations in neurofibromatosis 1 patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778305/ https://www.ncbi.nlm.nih.gov/pubmed/36553485 http://dx.doi.org/10.3390/genes13122218 |
work_keys_str_mv | AT tangjie assessmentofraregeneticvariantstoidentifycandidatemodifiergenesunderlyingneurologicalmanifestationsinneurofibromatosis1patients AT liniu assessmentofraregeneticvariantstoidentifycandidatemodifiergenesunderlyingneurologicalmanifestationsinneurofibromatosis1patients AT liguoqiang assessmentofraregeneticvariantstoidentifycandidatemodifiergenesunderlyingneurologicalmanifestationsinneurofibromatosis1patients AT wangjian assessmentofraregeneticvariantstoidentifycandidatemodifiergenesunderlyingneurologicalmanifestationsinneurofibromatosis1patients AT yutingting assessmentofraregeneticvariantstoidentifycandidatemodifiergenesunderlyingneurologicalmanifestationsinneurofibromatosis1patients AT yaoruen assessmentofraregeneticvariantstoidentifycandidatemodifiergenesunderlyingneurologicalmanifestationsinneurofibromatosis1patients |